Paul Tudor Jones Pacira Bio Sciences, Inc. Transaction History

Tudor Investment Corp Et Al

$15.5 Billion
Q1 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 23,244 shares of PCRX stock, worth $659,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,244

Holding current value

$659,664

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $643,858 - $824,697	23,244 New	23,244 $679,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $38,905 - $47,501	1,095 Added 4.59%	24,947 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $238,458 - $358,717	6,244 Added 35.46%	23,852 $921,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $902,233 - $1.04 Million	17,608 New	17,608 $937,000
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $4.85 Million - $7.7 Million	-94,265 Closed	0 $0

Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $2.94 Million - $3.75 Million	49,001 Added 108.26%	94,265 $7.19 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $167,031 - $216,615	-3,482 Reduced 7.14%	45,264 $2.72 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $2.66 Million - $2.99 Million	48,746 New	48,746 $2.73 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $1.38 Million - $1.63 Million	-23,302 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $1.38 Million - $1.84 Million	23,302 New	23,302 $1.63 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $286,378 - $487,866	-9,298 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $264,063 - $471,408	9,298 New	9,298 $312,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $2.54 Million - $3.28 Million	-69,949 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $1.29 Million - $1.62 Million	-36,052 Reduced 34.01%	69,949 $2.66 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $1.06 Million - $1.39 Million	29,013 Added 37.69%	106,001 $4.61 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $146,609 - $169,523	4,020 Added 5.51%	76,988 $2.93 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $705,698 - $891,049	17,083 Added 30.57%	72,968 $3.14 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $745,465 - $1.18 Million	22,693 Added 68.37%	55,885 $2.75 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $912,780 - $1.32 Million	33,192 New	33,192 $1.06 Million

Others Institutions Holding PCRX

# of Institutions

286

Shares Held

48.7M

Call Options Held

156K

Put Options Held

623K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.3B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account